Bio-Implants (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 33 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -29.64%
- Profit Growth -70.19%
- Ebitda 35.38%
- Net Worth -3.55%
- Total Assets -8.54%
About Bio-Implants (India)
Bio-Implants (India) Private Limited (BIPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 July 1991 and has a history of 33 years and six months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saroja Chellam and Jayasanker Shanthi serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52599TN1991PTC021166
-
Company No.
021166
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 1991
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Bio-Implants (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayasanker Shanthi
|
Managing Director | 13-Nov-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Saroja Chellam
|
Director | 24-Jul-1991 | Current |
Financial Performance of Bio-Implants (India).
Bio-Implants (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 29.64% decrease. The company also saw a substantial fall in profitability, with a 70.19% decrease in profit. The company's net worth dipped by a decrease of 3.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio-Implants (India)?
In 2020, Bio-Implants (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Reachgig Corporation Private LimitedJayasanker Shanthi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio-Implants (India)?
Unlock and access historical data on people associated with Bio-Implants (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio-Implants (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-Implants (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
